ZLDAF trading today higher at $0.26, an increase of 0% from yesterday's close, completing a monthly increase of 0% or $0. Over the past 12 months, ZLDAF stock lost -4.2886%.
ZLDAF is not paying dividends to its shareholders.
The last earnings report, released on Feb 24, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Zelira Therapeutics Limited has completed 1 stock splits, with the recent split occurring on Apr 14, 2022.
The company's stock is traded on 4 different exchanges and in various currencies, with the primary listing on ASX (AUD).